Related Experiment Videos
LNA-enhanced detection of single nucleotide polymorphisms in the apolipoprotein E
Nana Jacobsen1, Joan Bentzen, Michael Meldgaard
1Department of LNA Microarrays, Exiqon, Bygstubben 9, DK-2950 Vedbaek, Denmark. jacobsen@exiqon.com
Nucleic Acids Research
|October 5, 2002
Summary
This study introduces locked nucleic acid (LNA) capture probes and enhancers for accurate single nucleotide polymorphism (SNP) genotyping in challenging GC-rich regions. The novel method successfully genotyped apolipoprotein E (apoE) SNPs in patient samples, matching DNA sequencing results.
Area of Science:
- Biochemistry
- Genetics
- Molecular Biology
Background:
- Genotyping single nucleotide polymorphisms (SNPs) in GC-rich regions is challenging for large populations.
- The human apolipoprotein E (apoE) gene contains SNPs in GC-rich areas, like codon 112, complicating genotyping.
- Accurate SNP genotyping is crucial for population studies and disease association research.
Purpose of the Study:
- To develop an efficient and specific method for interrogating SNPs in GC-rich regions.
- To evaluate the utility of locked nucleic acid (LNA) capture probes and LNA-enhancer oligonucleotides for SNP genotyping.
- To apply the developed assay for genotyping apoE SNPs in patient samples.
Main Methods:
- Immobilized locked nucleic acid (LNA) capture probes were utilized.
- LNA-enhancer oligonucleotides were employed in conjunction with capture probes.
- The assay was validated by comparing results with DNA sequencing for patient samples.
Main Results:
- The combination of LNA capture probes and LNA enhancers enabled efficient and specific SNP interrogation.
- The method demonstrated excellent mismatch discrimination capabilities.
- All patient samples were unambiguously genotyped for apoE codons 112 and 158 SNPs, consistent with DNA sequencing data.
Conclusions:
- LNA oligonucleotide capture probes combined with LNA enhancers provide a robust solution for SNP genotyping in difficult sequences.
- This approach offers high specificity and accuracy, even in GC-rich environments.
- The validated assay is suitable for reliable apoE genotyping in clinical and research settings.